CN Stock MarketDetailed Quotes
002898 Sailong Pharmaceutical Group
- 9.76
- +0.02+0.21%
Trading Jan 21 09:44 CST
1.72BMarket Cap1084.44P/E (TTM)
9.80High9.67Low6.20KlotVolume9.74Open9.74Pre Close6.03MTurnover0.61%Turnover Ratio180.74P/E (Static)176.00MShares13.1852wk High3.25P/B988.32MFloat Cap7.6852wk Low10.71Limit Up101.26MShs Float30.73Historical High8.77Limit Down1.34%Amplitude7.42Historical Low0.02Dividend TTM9.73Avg Price2.62KlotAsk0.20%Div YieldTTM100Lot Size3.54KlotBid
Sailong Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -38.15%130.85M | -55.97%64.3M | -50.24%33.35M | 11.20%277.05M | 30.44%211.55M | 53.24%146.04M | 58.83%67.01M | -1.72%249.15M | -4.60%162.17M | -18.65%95.3M |
| Refunds of taxes and levies | 7.63%1.82M | -37.34%1.06M | 22.76%1.06M | -88.97%1.89M | -90.71%1.69M | -90.27%1.69M | --862.6K | --17.14M | 6,804.16%18.2M | --17.37M |
| Cash received relating to other operating activities | -45.79%3.91M | -89.28%774.12K | -82.90%231.38K | 208.56%23.14M | 267.17%7.22M | 499.94%7.22M | -22.83%1.35M | -10.82%7.5M | -30.86%1.97M | -15.13%1.2M |
| Cash inflows from operating activities | -38.05%136.59M | -57.32%66.13M | -49.96%34.64M | 10.33%302.08M | 20.91%220.46M | 36.07%154.95M | 57.53%69.22M | 4.53%273.79M | 5.33%182.34M | -3.96%113.87M |
| Goods services cash paid | -11.84%58.97M | -26.81%35.79M | -32.03%13.43M | 31.57%94.69M | 25.44%66.89M | 76.75%48.9M | 39.68%19.75M | 9.16%71.97M | 65.75%53.33M | 43.71%27.66M |
| Staff behalf paid | -3.09%47.97M | -5.63%31.54M | -10.42%16.17M | 27.81%65.23M | 41.97%49.5M | 43.27%33.42M | 41.84%18.05M | 26.24%51.04M | 13.53%34.87M | 11.15%23.33M |
| All taxes paid | -30.71%18.25M | -35.01%11.82M | -44.95%6.38M | 56.60%29.09M | 117.67%26.34M | 180.33%18.18M | 185.23%11.58M | 5.97%18.58M | -13.22%12.1M | -23.62%6.49M |
| Cash paid relating to other operating activities | -42.42%43.12M | -39.79%31.5M | -36.58%16.1M | -34.49%77.36M | -15.85%74.89M | -4.75%52.32M | -20.78%25.39M | 15.12%118.08M | -3.62%89M | -11.03%54.93M |
| Cash outflows from operating activities | -22.66%168.32M | -27.60%110.65M | -30.36%52.07M | 2.58%266.37M | 14.97%217.63M | 35.95%152.83M | 18.73%74.77M | 14.66%259.67M | 11.90%189.3M | 1.75%112.41M |
| Net cash flows from operating activities | -1,220.30%-31.73M | -2,195.23%-44.52M | -214.04%-17.44M | 152.80%35.71M | 140.70%2.83M | 45.62%2.12M | 70.84%-5.55M | -60.17%14.12M | -276.88%-6.96M | -81.97%1.46M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 22.05%115.95M | 360.59%92.13M | --90M | --152.87M | --95M | --20M | ---- | --0 | ---- | ---- |
| Cash received from returns on investments | -38.53%116.89K | 2,403.50%110.49K | --71.55K | --348.3K | --190.17K | --4.41K | ---- | --0 | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 412.44%14.17M | 197.64%8.21M | --7.11M | 1,033.36%13.04M | 131.78%2.76M | 2,870.54%2.76M | ---- | 295.48%1.15M | 8,420.61%1.19M | --92.88K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -53.73%3.24M | -53.73%3.24M | 7.96%3.24M |
| Cash received relating to other investing activities | ---- | ---- | 83.31%133.01K | ---- | -67.84%310.07K | -65.00%226.99K | -79.31%72.56K | -8.13%1.2M | -13.03%964.02K | -21.19%648.55K |
| Cash inflows from investing activities | 32.53%130.23M | 336.88%100.45M | 134,016.66%97.31M | 2,873.24%166.26M | 1,721.21%98.27M | 477.67%22.99M | -97.98%72.56K | -91.90%5.59M | -35.17%5.4M | -1.06%3.98M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -6.58%18.21M | -8.43%11.34M | 18.11%6.13M | 27.72%30.58M | 25.29%19.49M | -26.35%12.39M | -10.86%5.19M | -23.93%23.94M | -18.91%15.56M | 4.39%16.82M |
| Cash paid to acquire investments | -0.95%123.82M | 157.12%90M | --90M | --155M | --125M | --35M | ---- | --0 | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash paid relating to other investing activities | 91.65%2.3K | 524.89%1.25K | --1.25K | ---- | --1.2K | --200.02 | ---- | --0 | ---- | ---- |
| Cash outflows from investing activities | -1.71%142.03M | 113.85%101.34M | 1,752.60%96.13M | 675.12%185.58M | 828.74%144.5M | 181.73%47.39M | -10.86%5.19M | -73.83%23.94M | -18.91%15.56M | 4.39%16.82M |
| Net cash flows from investing activities | 74.48%-11.8M | 96.34%-892.9K | 123.20%1.19M | -5.31%-19.33M | -354.89%-46.23M | -90.00%-24.4M | -129.30%-5.12M | 18.37%-18.35M | 6.46%-10.16M | -6.20%-12.84M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from borrowing | 15.59%98.25M | -17.72%69.94M | -33.33%20M | 15.01%115M | -5.55%85M | 6.26%85M | -39.99%30M | -34.82%99.99M | -27.07%89.99M | -27.93%79.99M |
| Cash received relating to other financing activities | --0 | ---- | ---- | --30M | --30M | --30M | --30M | --0 | ---- | ---- |
| Cash inflows from financing activities | -14.56%98.25M | -39.18%69.94M | -66.67%20M | 45.01%145M | 27.79%115M | 43.76%115M | 20.02%60M | -34.82%99.99M | -27.07%89.99M | -27.93%79.99M |
| Borrowing repayment | -43.44%65.42M | -39.14%65.42M | -57.14%30M | 1.69%130.95M | 10.18%115.67M | 26.48%107.5M | 39.99%69.99M | 26.58%128.78M | 29.83%104.99M | 19.92%84.99M |
| Dividend interest payment | 86.05%7.36M | 88.53%6.2M | -47.01%842.53K | -35.84%5.58M | -44.83%3.96M | -41.32%3.29M | -41.50%1.59M | 10.19%8.7M | 23.69%7.17M | 45.04%5.61M |
| Cash payments relating to other financing activities | 11.55%8.59M | 177.10%5.7M | 76.36%3.48M | 971.88%10.35M | 875.30%7.7M | 286.76%2.06M | 16,824.16%1.97M | -24.02%965.36K | 1,187.78%789.57K | 1,719.36%531.48K |
| Cash outflows from financing activities | -36.09%81.37M | -31.48%77.32M | -53.34%34.32M | 6.10%146.88M | 12.73%127.33M | 23.83%112.84M | 39.50%73.56M | 24.83%138.44M | 30.23%112.95M | 21.89%91.13M |
| Net cash flows from financing activities | 236.84%16.88M | -441.69%-7.38M | -5.65%-14.32M | 95.11%-1.88M | 46.29%-12.33M | 119.39%2.16M | -395.49%-13.56M | -190.47%-38.45M | -162.62%-22.96M | -130.73%-11.13M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net increase in cash and cash equivalents | 52.17%-26.65M | -162.45%-52.79M | -26.20%-30.57M | 133.98%14.5M | -39.03%-55.73M | 10.67%-20.11M | -0.92%-24.23M | -176.92%-42.67M | -234.78%-40.08M | -169.86%-22.52M |
| Add:Begin period cash and cash equivalents | 20.54%85.11M | 20.54%85.11M | 20.54%85.11M | -37.67%70.6M | -37.67%70.6M | -37.67%70.6M | -37.67%70.6M | 95.99%113.28M | 95.99%113.28M | 95.99%113.28M |
| End period cash equivalent | 292.95%58.45M | -35.99%32.32M | 17.58%54.53M | 20.54%85.11M | -79.68%14.88M | -44.37%50.49M | -48.05%46.38M | -37.67%70.6M | -16.38%73.19M | 0.82%90.76M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
